A.F.P. Planvital S.A.

—

What it is

AFP PlanVital is a Chilean pension fund administrator, incorporated in 1981 to manage the individual savings accounts intended to finance workers’ retirement in Chile. Under Chilean law, every employee must contribute part of their wages to one of these administrators, making the client base captive by statute.

The company’s activities include collecting contributions, managing individual capitalisation accounts, and providing life and disability benefits, funeral expense payments, and retirement pensions. As of August 2024, it held roughly USD 11bn in assets under management, giving it a market share of about 5.6% — the smallest of Chile’s active AFP operators.

—

Who owns it

PlanVital is a Chilean subsidiary of Italian insurer Assicurazioni Generali S.p.A., which holds a 100% economic interest. Generali directly controls 86.11% of the shares, with the remainder held through related vehicles, consistent with the EODHD figure showing insiders at 99.0% and institutional investors at just 0.1% — meaning the public float is effectively nil, which explains the meaningless published P/E ratio.

Generali itself has a presence in 50 countries across Europe, Asia, Africa, and the Americas, and managed roughly €500bn in assets as of end-2019. PlanVital is a small but high-margin outpost in its Latin American footprint.

—

Who runs it

José Joaquín Prat Errázuriz was appointed CEO in September 2024. He succeeded Andrea Battini after a five-year tenure, and brings 18 years of experience in the Chilean pension system.

Prat joined PlanVital in 2006, held leadership roles across legal, compliance, and risk management, and became General Manager in August 2019. The CFO is not disclosed in available public sources; Diego Dziekonski Vásquez serves as Chief Investment Officer.

—

The money, in plain words

Revenue has grown at roughly 10% a year for two consecutive years — from CLP 107.8bn (~USD 119m) in 2023 to CLP 131.8bn (~USD 145.5m) in 2025, a cumulative gain of 22% in two years (our calculation). For every peso it collects in fees, it keeps about 44 cents as net profit — a net margin of 44.3% on a trailing basis, extraordinary for any financial business.

For every peso shareholders have put in, PlanVital earns back about 43 cents a year — a return on equity of 43.2%, which reflects both the pricing power of a legally mandated service and a lean cost base of 842 people. The company carries CLP 44.0bn (~USD 48.6m) in cash and zero reported debt — net cash of CLP 44.0bn (US$49 mn) — and pays no dividend, meaning all earnings are retained (our calculation).

—

What it is doing now

Chile’s Congress approved a landmark pension reform on 29 January 2025, aimed at making the system more equitable and gender-inclusive. From August 2025, the existing private-account system transitions to a new mixed model that combines individual AFP accounts with a new state-run social security fund, the FAPP.

From April 2027, the current five risk-tier funds will be replaced by ten age-based target-date funds, and a public bidding process will reassign 10% of individual accounts every two years to the AFP charging the lowest commission. For PlanVital — already the smallest AFP by assets — winning or losing those biennial tenders will be the single most consequential competitive event of the next decade.

—

What to watch

• The 2027 fee bidding: PlanVital has historically competed on low commissions; the new mandatory tender system is structurally designed around that advantage — but only if it can hold its cost base down.
• Generali’s strategic intent: With a 99% ownership grip and zero dividend paid out, the parent is keeping all capital inside. Whether Generali grows, sells, or lists a minority stake is the ownership question that matters most.
• Revenue trajectory: Two straight years of ~10% growth suggest the mandatory-contribution base is expanding; watch whether the new employer contributions flowing from August 2025 accelerate that line further.
• Margin sustainability: A 44% net margin in a business facing new regulatory price competition is a high-water mark; any fee cap in the new bidding regime will test whether PlanVital’s low-cost model is durable or just a legacy of thin investment in the platform.

—

This is news, not investment advice.